Search - tctmd.com

Displaying 1 - 2 of 2

Sort: Relevancy | Date

Icosapent Ethyl Lowers Revasc Rates Across the Board: REDUCE-IT Data

News Conference News SCAI 2020

Icosapent Ethyl Lowers Revasc Rates Across the Board: REDUCE-IT Data

May 15, 2020

News Industry News

First patient enrolled in Pivotal's POMEGA Phase IIa clinical trial with PVT-100

June 04, 2015

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.